Narrow band UVB phototherapy for patients with Clinically Isolated Syndrome: A phase 1 trial

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1067209

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The environment, particularly lack of sunlight exposure, contributes to the incidence and progression of multiple sclerosis. We will give patients with early multiple sclerosis controlled exposure to ultraviolet light and then measure biomarkers of their disease activity over the next 12 months. The therapy is safe and is used for treatment of patients with psoriasis. Patients should gain benefits from sunlight-induced vitamin D, as well as other sunlight-induced molecules.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $682,803.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Neurology and Neuromuscular Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

autoimmunity | biomarkers | clinical trial | multiple sclerosis (MS) | phototherapy | regulatory T cells | ultraviolet (UV) irradiation | vitamin D

Related Links